Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2020 R33 RFA-CA-19-020 MATRIX BHATNAGAR, PARIJAT SRI INTERNATIONAL T-cell Biofactories For Targeting Extracellular Matrix Active
2019 R21 RFA-CA-18-002 MONTAGNA, CRISTINA ALBERT EINSTEIN COLLEGE OF MEDICINE Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions Active
2022 R21 CA21-003 LIN, QIAO COLUMBIA UNIV NEW YORK MORNINGSIDE A Practical Approach to Tumor-Specific Aptamers for B-Cell Hematologic Malignancies Active
2021 R44 PAR-18-303 HUNG, PAUL JU-SUNG COMBINATI, INC. Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring Active
2020 R33 RFA-CA-19-020 COOKS, ROBERT GRAHAM PURDUE UNIVERSITY Advanced Development Of Desorption Electrospray Ionization Mass Spectrometry For Intraoperative Molecular Diagnosis Of Brain Cancer Using Pathology Biopsies Active
2019 R33 RFA-CA-18-003 KETTENBACH, ARMINJA NADINE DARTMOUTH COLLEGE Activity based profiling of Phosphoprotein phosphatases in cancer using mass spectrometry-based proteomics Active
2022 R21 CA21-003 YAKOVLEV, VLADISLAV V TEXAS ENGINEERING EXPERIMENT STATION Molecular and cellular imaging of bone biopsies using AI augmented deep UV Raman microscopy Active
2020 R21 RFA-CA-19-021 GUPTA, GAUTAM UNIVERSITY OF LOUISVILLE Bio Cargos: Capture And Release Gels For Optimized Storage Of Cancer Biospecimens Active
2019 R33 RFA-CA-18-003 CHEN, SIDI YALE UNIVERSITY Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers Active
2022 R33 CA21-004 CHIU, BRIAN C-H UNIVERSITY OF CHICAGO A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research Active
2020 R44 PAR-18-303 GURARD-LEVIN, ZACHARY SAMDI TECH, INC. Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities Active
2019 R33 RFA-CA-18-003 TAVANA, HOSSEIN UNIVERSITY OF AKRON A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery Active
2018 R33 RFA-CA-17-011 SCHRUM, ADAM G UNIVERSITY OF MISSOURI-COLUMBIA Multiplex matrix ELISA for T cell protein-interaction networks in cancer Active
2022 R21 CA21-003 BLAINEY, PAUL CLARK BROAD INSTITUTE, INC. Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout Active
2020 R21 RFA-CA-19-019 HATTORI, TAKAMITSU NEW YORK UNIVERSITY SCHOOL OF MEDICINE Rational Generation Of High-performance Recombinant Antibodies To Post-translational Modifications Active
2019 R33 RFA-CA-18-003 SCHNECK, JONATHAN P JOHNS HOPKINS UNIVERSITY A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells Active
2018 R33 RFA-CA-17-011 TEWARI, MUNEESH (contact); WALTER, NILS G UNIVERSITY OF MICHIGAN AT ANN ARBOR Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations Active
2022 R21 CA21-003 SALIPANTE, STEPHEN J UNIVERSITY OF WASHINGTON Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations Active
1999 R43 PAR-98-066 HAGEN, FREDERICK S ICOGENEX CORPORATION AFFINITY AND TRANSCRIPTASE TECHNOLOGIES Complete
2001 R44 PAR-99-101 BITTER, GRANT A. BITTECH, INC. DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS Complete
2004 R44 PAR-01-105 BATTRELL, CHARLES FRED MICRONICS, INC. MICROFLUIDIC POINT-OF-CARE CANCER CELL ANALYZER Complete
2007 R42 RFA-CA-07-011 RAMPERSAUD, ARFAAN COLUMBUS NANOWORKS, INC. COMMERCIALIZATION OF MAGNETIC NANOBEADS FOR CANCER CELL ENRICHMENT Complete
2010 R33 RFA-CA-09-005 WANG, SHAN X. STANFORD UNIVERSITY CANCER SAMPLE PREPARATION WITH MICROMACHINED MAGNETIC SIFTER AND NANOPARTICLES Complete
2014 R33 RFA-CA-13-004 HANSEN, KIRK C UNIVERSITY OF COLORADO DENVER ADVANCED METHODS TO EVALUATE EXTRACELLULAR MATRIX AND CROSSLINKING IN THE TUMOR M Complete
2017 R33 RFA-CA-16-002 LU, CHANG VIRGINIA POLYTECHNIC INST AND ST UNIV Next-generation MOWChIP-seq for high-throughput epigenomic profiling using clinically relevant samples Complete
2021 R21 CA20-019 AKSAN, ALPTEKIN UNIVERSITY OF MINNESOTA Novel cryopreservation method for stabilization of manufactured therapeutic cells Complete
1999 R21 PAR-98-067 WIGLER, MICHAEL H COLD SPRING HARBOR LABORATORY REPRESENTATIONAL APPROACHES TO GENOMIC ANALYSIS Complete
2001 R33 PAR-98-067 WANG, YUE CATHOLIC UNIVERSITY OF AMERICA INTELLIGENT MAPPING OF GENE EXPRESSION PROFILES Complete
2003 R43 PAR-01-105 KRIZMAN, DAVID BURKE EXPRESSION PATHOLOGY, INC PROTEIN ARRAYS FOR MOLECULAR ANALYSIS OF CANCER TISSUE Complete
2007 R21 RFA-CA-07-002 MINDERMAN, HANS ROSWELL PARK CANCER INSTITUTE CORP CLINICAL APPLICATION OF MULTISPECTRAL IMAGING FLOW CYTOMETRY Complete
2009 R43 RFA-CA-08-011 RUIZ, JOSEPH C TRANSPOSAGEN BIOPHARMACEUTICALS, INC. TISSUE-SPECIFIC MUTAGENESIS IN RAT AS AN IN VIVO TOOL FOR COLON CANCER GENE DISCO Complete
2013 R33 RFA-CA-12-003 CUNNINGHAM, BRIAN T. UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN PHOTONIC CRYSTAL ENHANCED FLUORESCENCE: DEVELOPMENT OF SENSORS STRUCTURES AND DET Complete
2016 R33 RFA-CA-15-003 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY Protein painting identifies therapeutic targets at protein-protein interfaces Complete
2000 R43 PAR-99-101 GOLOVLEV, VAL V SCI-TEC, INC. MAGNETIC DISK ARRAY DNA ANALYZER Complete
2002 R43 PAR-01-105 HANCOCK, LAWRENCE F NOMADICS, INC. POLYMER AMPLIFIED NUCLEIC ACID DETECTION Complete
2006 R21 RFA-CA-06-003 WANG, BINGHE GEORGIA STATE UNIVERSITY MRI CONTRAST AGENTS TARGETING CARBOHYDRATE BIOMARKERS Complete
2009 R21 RFA-CA-08-006 TANNER, SCOTT DAVID UNIVERSITY OF TORONTO DEVELOPMENT OF (PROTOTYPE) BEAD ARRAY FLOW CYTOMETER WITH MASS SPECTROMETER DETEC Complete
2012 R33 RFA-CA-12-003 LAM, KIT S UNIVERSITY OF CALIFORNIA AT DAVIS DISCOVERY OF DEATH LIGANDS AGAINST CANCERS Complete
2016 R21 RFA-CA-15-002 LARMAN, HARRY BENJAMIN JOHNS HOPKINS UNIVERSITY A HIGHLY MULTIPLEXED GENE EXPRESSION PLATFORM FOR FIXED TISSUE SPECIMENS Complete
2000 R21 PAR-99-100 MALKHOSYAN, SERGEI R BURNHAM INSTITUTE FOR MEDICAL RESEARCH COMPARATIVE HYBRIDIZATION OF AP PCR ARRAYS Complete
2002 R33 PAR-01-104 SPEICHER, DAVID W. WISTAR INSTITUTE DEVELOPMENT OF METHODS FOR CANCER BIOMARKER DETECTION Complete
2005 R21 RFA-CA-05-004 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INSTITUTE GENOME AMPLIFICATION TOLERANT TO SAMPLE DEGRADATION Complete
2008 R21 RFA-CA-07-035 NOLTE, DAVID D PURDUE UNIVERSITY WEST LAFAYETTE MULTIPLEXED ASSAYS ON THE BIOCD FOR ACUTE LYMPHOCYTIC LEUKEMIA Complete
2011 R21 RFA-CA-10-005 LEVY, MATTHEW ALBERT EINSTEIN COLLEGE OF MEDICINE TARGETING CANCER CELLS WITH FUNCTIONALIZED NANOPARTICLE LIBRARIES Complete
2015 R21 RFA-CA-14-005 KRUMMEL, MATTHEW F UNIVERSITY OF CALIFORNIA, SAN FRANCISCO LIVING TUMOR BIOPSIES TO INTERROGATE IMMUNE FUNCTION AND RESPONSE TO THERAPY Complete
1999 R43 PAR-98-066 GERDES, JOHN CHARLES XTRANA, INC. QUANTITATION AND ARCHIVING OF GENE EXPRESSION Complete
2001 R44 PAR-99-101 GITE, SADANAND AMBERGEN, INC NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION Complete
2004 R44 PAR-01-105 BALGLEY, BRIAN M CALIBRANT BIOSYSTEMS, INC. INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS Complete
2007 R43 RFA-CA-07-010 BOGEN, STEVEN A MEDICAL DISCOVERY PARTNERS, LLC ISOLATION OF CIRCULATING TUMOR CELLS FROM PERIPHERAL BLOOD Complete
2010 R33 RFA-CA-09-007 BESTOR, TIMOTHY H COLUMBIA UNIVERSITY HEALTH SCIENCES MAMMARY CARCINOMA AND GENOMIC METHYLATION PATTERNS Complete

Pages